← ANALYST RATINGS · TIPRANKS

Balchem (BCPC): analyst forecast and price target

$171 +0.12% close 16.10.26 · market cap $5.4B · Basicmaterials · Chemicals - Specialty IWM 0.19%
Price targets and ratings of

Analyst consensus

Moderate Buy

1 Buy0 Hold0 Sell

Ratings of 1 analysts in the last 3 months

12-month forecast

$215+25.9% upside

Based on 1 price targets given in the last 3 months, the average target is $215, the highest $215, the lowest $215. The average is +25.9% from the last price of $171.

$160$180$200Jan 26AprJulOctJan 27AprJulOctHigh$215Average$215Low$215
Highest target $215 Average target $215 Lowest target $215
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Ram Selvaraju★★★★★★★★★★#212 · hits 57% · avg +24.4% H.C. Wainwright $190 → $215+13.2% Buy +25.9% Reiterated 03.08.26on TipRanks 06:15 +2.2%next day −1.1% · 5 days +0.1%
Daniel Harriman★★★★★★★★★★#8797 · hits 40% · avg −0.1% Sidoti $234 Buy +37.1% Reiterated 04.05.26on TipRanks 08:15 +0.7%next day −1.4% · 5 days −4.9%
Artem Chubarov★★★★★★★★★★#8387 · hits 100% · avg +6.6% Rothschild & Co Redburn $162 Hold −5.1% Initiated 05.12.25on TipRanks 05:15 −2.0%next day −1.8% · 5 days +4.2%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Balchem

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Ram Selvaraju★★★★★★★★★★H.C. Wainwright · #212
Hits 57%287 of 500 Average return +24.4%
1 year Ram Selvaraju★★★★★★★★★★H.C. Wainwright · #212
Hits 57%287 of 500 Average return +24.4%
2 years Ram Selvaraju★★★★★★★★★★H.C. Wainwright · #212
Hits 57%287 of 500 Average return +24.4%

Most profitable

3 months Ram Selvaraju★★★★★★★★★★H.C. Wainwright · #212
Hits 57%287 of 500 Average return +24.4%
1 year Ram Selvaraju★★★★★★★★★★H.C. Wainwright · #212
Hits 57%287 of 500 Average return +24.4%
2 years Ram Selvaraju★★★★★★★★★★H.C. Wainwright · #212
Hits 57%287 of 500 Average return +24.4%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $215 at a price of $165 (+30.3%); now: $215 at $171 (+25.9%).

$180$200Sep 15Oct 1Oct 15Top analysts$215Average target$215Price$171

PriceAverage targetTop analysts’ target

Recommendation trend

001122Oct 251Nov11Dec1Jan 2611Feb1Mar1Apr2May2Jun2Jul1Aug1Sep1Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy222111
Hold000000
Sell000000

Earnings and sales forecast

Next report: 23.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $1.43 (from $1.41 to $1.45). Last quarter: $1.39.

Sales

Next quarter’s sales estimate — $289M (from $285M to $292M). Last quarter: $284M.

Best top-analyst consensus in the sector · Basicmaterials

HBMnot in our ETFs
USARUSA Rare Earth
KGCnot in our ETFs
EQXnot in our ETFs
SSRMSSR Mining
About Balchem
  • CEO: Theodore L. Harris
  • Employees: 1,379
  • 5 Paragon Drive, Montvale, NJ, 07645, US
  • www.balchem.com

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Data from the stock’s TipRanks forecast page, read 377 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗